Micrima: Developing technology for breast cancer screening
A new breast cancer screening method in the future.
Micrima is a Bristol based diagnostic imaging company founded in 2006. Micrima is developing the MARIA® breast cancer detection system. This whole breast imaging system uses harmless radio-waves to detect breast cancer and requires no breast compression so should be more comfortable for women. Today MARIA® will identify area of interests that need further investigation with other modalities, however the future functionality looks exciting. Micrima have a growing database of patient data and it is hoped with the use of AI and this database, MARIA® will be able to further stratify lesions and possibly even differentiate cancer types.
MARIA® has been trialled so far in over 400 women in the United Kingdom. Further trials are taking place at leading European centres. Currently, MARIA® is being used in clinical trials in symptomatic clinics, but it is hoped in the future this may be a viable alternative for routine breast screening.
Micrima was bestowed the accolade of being voted the best new manufacturing company in the Medical, Life Sciences and Healthcare …
Micrima attended and helped sponsor this year’s annual meeting for the British Society of Breast Radiologists (BSBR). The event (held …